Hjem
Richard Allan Daviess bilde

Richard Allan Davies

Senioringeniør
  • E-postRichard.Davies@uib.no
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
  • Vis forfatter(e) (2022). Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren’s syndrome. Arthritis Research & Therapy. 12 sider.
  • Vis forfatter(e) (2022). Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4<sup>+</sup> T cell immunity within the FLUCOP consortium. Frontiers in Immunology. 14 sider.
  • Vis forfatter(e) (2022). Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. Frontiers in Immunology. 14 sider.
  • Vis forfatter(e) (2022). Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation. Frontiers in Immunology. 13 sider.
  • Vis forfatter(e) (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. Scandinavian Journal of Immunology. 1-9.
  • Vis forfatter(e) (2019). Single cell based phosphorylation profiling identifies alterations in toll-like receptor 7 and 9 signaling in patients with primary sjogren's syndrome. Frontiers in Immunology. 1-18.
  • Vis forfatter(e) (2018). Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab. British Journal of Dermatology. 371-380.
  • Vis forfatter(e) (2018). Improving influenza vaccines: challenges to effective implementation. Current Opinion in Immunology. 88-95.

Se fullstendig oversikt over publikasjoner i CRIStin.